Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3

Watchlist Manager
Hapvida Participacoes e Investimentos SA Logo
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Watchlist
Price: 2.25 BRL -5.46%
Market Cap: 17B BRL
Have any thoughts about
Hapvida Participacoes e Investimentos SA?
Write Note

Net Margin
Hapvida Participacoes e Investimentos SA

-2.6%
Current
-1%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2.6%
=
Net Income
-427.5m
/
Revenue
16.4B

Net Margin Across Competitors

Country BR
Market Cap 16.9B BRL
Net Margin
-3%
Country US
Market Cap 465.5B USD
Net Margin
4%
Country US
Market Cap 95.5B USD
Net Margin
4%
Country US
Market Cap 86.3B USD
Net Margin
4%
Country US
Market Cap 30.7B USD
Net Margin
1%
Country US
Market Cap 30.7B USD
Net Margin
2%
Country US
Market Cap 16.8B USD
Net Margin
3%
Country US
Market Cap 8.3B USD
Net Margin
8%
Country US
Market Cap 2.2B EUR
Net Margin
6%
Country US
Market Cap 1.6B USD
Net Margin
-6%
Country US
Market Cap 1.3B USD
Net Margin
5%
No Stocks Found

Hapvida Participacoes e Investimentos SA
Glance View

Market Cap
16.9B BRL
Industry
Health Care

Hapvida Participações e Investimentos SA stands as a prominent player in Brazil's healthcare landscape, weaving an intricate tapestry of innovation and tradition in the nation's burgeoning private health sector. Headquartered in Fortaleza, this integrated health company began its journey in 1993. Initially, it was a small hospital that sought to address Brazil’s growing demand for accessible and comprehensive healthcare services. Over the years, Hapvida expanded its horizons by building a vast network that now includes hospitals, clinics, and laboratories scattered strategically across the country. This robust infrastructure forms the backbone of its operations, allowing the company to provide a seamless patient experience from diagnosis to aftercare. Driven by a commitment to technology, Hapvida harnesses advanced medical platforms to streamline its services, ensuring efficiency and cost-effectiveness, thus reinforcing its reputation as a leader in value-based healthcare. Hapvida’s business model thrives on vertical integration, a strategic choice that aligns various facets of healthcare delivery under one umbrella. This model not only enhances operational control but also reduces costs—a critical factor in a diverse and complex market like Brazil. By owning and managing its entire network of facilities, Hapvida enjoys significant bargaining power, enabling it to offer competitive pricing for its health plans. The company’s revenue is largely generated from these health insurance plans, which are marketed to individuals and corporate clients seeking affordable private healthcare options. Simultaneously, its owned hospitals and clinics serve as revenue streams through direct patient care services. Through this dual approach, Hapvida not only ensures steady income but also fortifies its standing as a trusted provider of health services, catering to millions and redefining the standards of private healthcare in Brazil.

HAPV3 Intrinsic Value
4.18 BRL
Undervaluation 46%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-2.6%
=
Net Income
-427.5m
/
Revenue
16.4B
What is the Net Margin of Hapvida Participacoes e Investimentos SA?

Based on Hapvida Participacoes e Investimentos SA's most recent financial statements, the company has Net Margin of -2.6%.